Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study
暂无分享,去创建一个
T. Brümmendorf | H. Kantarjian | J. Cortes | J. Lipton | H. Khoury | E. Leip | C. Gambacorti-Passerini | Dong-Wook Kim | P. Schafhausen | N. Bardy-Bouxin | M. Shapiro | R. Crescenzo | K. Noonan | L. Deannuntis | L. DeAnnuntis